Tech Company Financing Transactions

Leptos Biomedical Funding Round

Leptos Biomedical, based in Fridley, received $20 million in investment from Latterell Venture Partners, Spray Venture Partners and Technology Partners.

Transaction Overview

Company Name
Announced On
8/16/2007
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series C
Investors

Latterell Venture Partners (Lead Investor)

Spray Venture Partners (Kevin Connors)

Technology Partners (James Glasheen)

Thomas, McNerny & Partners (Karen Boezi)

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Out of Business
Industry
Medical Devices & Instruments
Mailing Address
452 Northco Drive 100
Fridley, MN 55432
USA
Email Address
Overview
Leptos is developing a proprietary neuromodulation therapy for chronic obesity. The treatment, delivered via a pacemaker-type device, involves electrical activation of a specific nerve in the autonomic nervous system.
Profile
Leptos Biomedical LinkedIn Company Profile
Social Media
Leptos Biomedical Company Twitter Account
Company News
Leptos Biomedical News
Facebook
Leptos Biomedical on Facebook
YouTube
Leptos Biomedical on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Hans Neisz
  Hans Neisz LinkedIn Profile  Hans Neisz Twitter Account  Hans Neisz News  Hans Neisz on Facebook


 

 

Browse more venture capital transactions:

Prev: 8/15/2007: ARC Solutions venture capital transaction
Next: 8/16/2007: Ethos Networks venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

We do our best to record tech company VC transactions. VC transactions on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary